While toxicities observed with traditional chemotherapeutic drugs are not observed when VEGF neutralizing drugs are employed as monotherapy against tumor angiogenesis, the combination of these drugs with chemotherapy results in increased toxicity. The gene discussed is VEGFA; the disease is neoplasm.